VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by europe10on Oct 23, 2013 8:31am

138 Views

Post# 21840114

RE:RE:RE:RE:RE:RE:News Release Out, Any Comments?

Volume lately could indicate that larger investors are getting involved. If that is the case it could explain the increase of the PP. It might have been a demand from new investors to get involved.
I suspect is has to be done at 10 cents as that was the level when the PP was announced.
The constant dilution is worrying though.
Then again - it is all about FDA. No = stock at 1 cent instantly.
Yes = company must prove they can sell the product!
Expect no rush towards 50 cents or above until that is proven.

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload